Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124049232 | 12404923 | 2 | F | 2006 | 20160704 | 20160525 | 20160718 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201605008306 | ELI LILLY AND CO | 0.00 | F | Y | 70.00000 | KG | 20160715 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124049232 | 12404923 | 1 | PS | HUMULIN R | INSULIN HUMAN | 1 | Subcutaneous | 20 IU, BEFORE LUNCH | C562466 | 18780 | 20 | IU | INJECTION | ||||||
| 124049232 | 12404923 | 2 | SS | HUMULIN R | INSULIN HUMAN | 1 | Subcutaneous | 20 IU, BEFORE DINNER | C562466 | 18780 | 20 | IU | INJECTION | ||||||
| 124049232 | 12404923 | 3 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 124049232 | 12404923 | 4 | C | PLENANCE | ROSUVASTATIN | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 124049232 | 12404923 | 5 | C | LUCENTIS | RANIBIZUMAB | 1 | UNK, UNKNOWN | U | 0 | ||||||||||
| 124049232 | 12404923 | 6 | C | HUMULIN N | INSULIN HUMAN | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124049232 | 12404923 | 1 | Type 2 diabetes mellitus |
| 124049232 | 12404923 | 4 | Carotid artery occlusion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124049232 | 12404923 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124049232 | 12404923 | Blood cholesterol increased | |
| 124049232 | 12404923 | Blood triglycerides increased | |
| 124049232 | 12404923 | Carotid artery occlusion | |
| 124049232 | 12404923 | Cataract | |
| 124049232 | 12404923 | Glaucoma | |
| 124049232 | 12404923 | Hyperglycaemia | |
| 124049232 | 12404923 | Hypertension | |
| 124049232 | 12404923 | Hypoaesthesia | |
| 124049232 | 12404923 | Hypoglycaemia | |
| 124049232 | 12404923 | Iris neovascularisation | |
| 124049232 | 12404923 | Stasis dermatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124049232 | 12404923 | 1 | 2006 | 0 | ||
| 124049232 | 12404923 | 2 | 2006 | 0 |